Gerald E. Connolly Esophageal Cancer Awareness Act of 2025
- Sponsor
- Sen. Warner, Mark R. [D-VA]
- Committees
- Homeland Security and Governmental Affairs Committee (primary)
- Last action
- Jun 3, 2025
Bottom line
The bill requires a GAO report to shed light on esophageal cancer's financial impact on federal employee health plans and screening practices for high-risk individuals.
What it actually does
This bill mandates the Comptroller General of the United States (GAO) to conduct and submit a report to Congress within one year. The report will evaluate the total healthcare spending related to esophageal cancer within the Federal Employees Health Benefits Program (FEHBP) and assess the frequency of esophageal cancer screenings among high-risk individuals covered by FEHBP, based on established medical guidelines.
Proponents argue
Supporters argue that this bill is a crucial step towards understanding and combating esophageal cancer, which is rapidly increasing and often deadly due to late detection. By requiring a GAO report, the bill will provide essential data on healthcare spending and screening rates within the FEHBP, enabling Congress to identify gaps in care and inform future policy decisions aimed at improving early detection and survival rates for federal employees and potentially serving as a model for broader health initiatives.
Opponents contend
Critics might argue that while the intent is laudable, mandating specific reports from the GAO can divert resources from other critical oversight functions. They might also contend that the FEHBP already has mechanisms for data collection and analysis, and a new, specific report might be redundant or less efficient than leveraging existing data streams. Some might also question the scope, suggesting that focusing solely on federal employees might not provide a comprehensive national picture.
The bill is very short and easy to read, allowing for quick comprehension of its purpose and provisions.
Section 3
Comptroller General Report on Esophageal Cancer in FEHBP
This section directs the Comptroller General of the United States (who heads the Government Accountability Office, or GAO) to produce a report for Congress within one year. This report must analyze two key areas: first, the total amount of money spent on healthcare for federal employees diagnosed with esophageal cancer under the Federal Employees Health Benefits Program (FEHBP); and second, how often FEHBP participants who are identified as high-risk for esophageal cancer actually receive recommended screenings.
Supporters argue
Supporters argue that this report is essential for evidence-based policymaking. By quantifying the financial burden of esophageal cancer within FEHBP and identifying screening gaps, Congress can develop targeted interventions to improve early detection, reduce treatment costs, and ultimately save lives among federal employees. The findings could also highlight best practices or areas for improvement in health insurance coverage and preventative care.
Critics contend
Some might argue that while data is valuable, the GAO's resources are finite, and mandating this specific report might divert attention from other pressing oversight needs. They might suggest that existing agencies or internal FEHBP data collection could provide similar insights more efficiently, or that a broader study across all insured populations might yield more generalizable results.
Tradeoffs
The bill balances the need for specific, actionable data on a critical health issue against the administrative burden on the GAO and the potential for narrow focus. It prioritizes understanding a specific health challenge within a defined population (FEHBP) to inform potential future health policy.